Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,600 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Clinical Proteomics, 2026Evaluation of the relationship between inflammation and typical chest pain in ST-elevation myocardial infarction
Wolfermann S., Schmitz T., Raake P. et al.
Olink Target 96
Frontiers in Immunology, 2026Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
Wang J., Pan S., Xiong C. et al.
Nature, 2026Immune evasive DNA donors and recombinases license kilobase-scale writing
Tou C., Xie K., Ferreira da Silva J. et al.
Olink Target 48 Mouse
Naunyn-Schmiedeberg's Archives of Pharmacology, 2026Constructing a protein–protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses
Tian D., Yang Z., Zhao L. et al.
Olink Explore 3072/384
Journal of Alzheimer's Disease Reports, 2026Exploring potential genetic correlation and causality between cathepsins and neurodegenerative diseases: Insight from Mendelian randomization analyses
Shu H., He R., Zhu Z. et al.
Signal Transduction and Targeted Therapy, 2026Distinct metabolomic and proteomic signatures in Parkinson’s disease patients with REM sleep behavior disorder
Shao Y., Wang J., Liu Y. et al.
International Journal of Cancer, 2026 ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance
Sánchez‐Maldonado J., Macauda A., Cabrera‐Serrano A. et al.
Frontiers in Immunology, 2026HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis
Ruberto S., Dominguez-Mozo M., Villar L. et al.
Olink Target 48
Virology Journal, 2026Ferritin nanoparticles displaying rift valley fever virus glycoprotein elicit potent dendritic cell activation in vitro
Rodrigues M., Cardoso I., Duarte N. et al.
Olink Flex
Journal of Diabetes and its Complications, 2026Circulating proteomic markers are associated with measures of small and large fiber neuropathy and symptoms in type 2 diabetes
Ponirakis G., Al-Janahi I., Elgassim E. et al.
Skin Appendage Disorders, 2026Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
Pan L., Li C., Yang L.
Communications Biology, 2019High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
Enroth S., Berggrund M., Lycke M. et al.
Pediatric Critical Care Medicine, 2026Distinct Blood and Lung Proteins Drive Pulmonary Capillary Leak in Children With Severe Hypoxemic Respiratory Failure
Gkaifyllia A., Bruzek S., Ignjatovic V. et al.
Brain Communications, 2026Peripheral immune profiling in frontotemporal dementia
Gamez N., Eid A., Pascual B. et al.
JCO Oncology Advances, 2026Tumor-Targeted IL-12 (PDS01ADC) With Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Nonrandomized Phase II Trial
Eade A., Smith E., Monge C. et al.
Pediatric Critical Care Medicine, 2026Arterial Catheter-Associated Proximal Ischemic Injury in Critically Ill Children: Evidence of Endothelial Dysfunction and Immune Dysregulation
Demopoulos A., Weber M., Liu H. et al.
Neurotherapeutics, 2026Longitudinal multi-omics profiling of spinal muscular atrophy
Dabaj I., Nguyen T., Lagrue E. et al.
Clinical Proteomics, 2026Proximity extension assay-based serum proteomic profiling identifies shared protein signatures in hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders
Cinquina V., Carini G., Chiarelli N. et al.
Molecular Psychiatry, 2026Large-scale proteomic analyses before depression diagnosis reveal novel pathophysiological insights
Cheng B., Cheng S., Pan C. et al.
iScience, 2026Genetic evidence for causal roles of circulating proteins on breast cancer susceptibility
Chen H., Liu Q., Zhao H. et al.
3774 publications
Items per page
21-40 of 3774 publications